BioCentury | Nov 23, 2020
Emerging Company Profile

SV Health-incubated Catamaran debuts with $42M to develop CAR NK pipeline

...led the A round, which also saw participation from SV Health, Takeda Ventures and Astellas Venture Management. COMPANY...
BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...saw participation from new investors Qiming Venture Partners USA, Surveyor Capital, Cormorant Asset Management, MP Healthcare Venture Management...
BioCentury | Jul 21, 2020
Deals

With deal for Tizona, Gilead places latest bet on cancer immunosuppression

...MPM’s Luke Evnin holds a board seat. Other series A investors included Amgen Ventures, Astellas Venture Management...
BioCentury | May 29, 2020
Finance

Taiho’s new modality search engine

...corporate venture fund in 2016, after a four-year stint as president and CEO of Astellas Venture Management...
BioCentury | May 13, 2020
Emerging Company Profile

QurAlis taking three ALS programs toward clinic with $42M series A

...Also participating were Droia Ventures, Mitsui Global Investment, Dolby Family Ventures, Amgen Ventures, MP Healthcare Venture Management...
...Dementia Discovery Fund, Droia Ventures, Mitsui Global Investment, Dolby Family Ventures, Amgen Ventures, MP Healthcare Venture Management...
BioCentury | Mar 27, 2020
Emerging Company Profile

Redpin debuts chemogenetic platform for neurology, raises $15.5M

...has raised $34 million in series A funding from Versant Ventures, MPM Capital and Astellas Venture Management...
BioCentury | Jan 10, 2020
Financial News

Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas

...participation by new investors Novartis Institutes for BioMedical Research (NIBR), Pitango Venture Capital, and Astellas Venture Management...
BioCentury | Nov 5, 2019
Finance

Coda’s chemogenetics convinces investors to re-up in series A extension

...Ventures, brings the round’s total to $34 million. Fellow existing investors MPM Capital and Astellas Venture Management...
BioCentury | Sep 16, 2019
Financial News

Sept. 16 Financial Quick Takes: Karyopharm, Mission Bay, Autolus, BenevolentAI, Edigene

...$60 million and said Robert Blazej has joined the firm’s management team. LPs include Astellas Venture Management...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...participating were existing investors MPM Capital, Deerfield Management, UBS Oncology Impact Fund, Arkin Bioventures, Astellas Venture Management...
Items per page:
1 - 10 of 349
BioCentury | Nov 23, 2020
Emerging Company Profile

SV Health-incubated Catamaran debuts with $42M to develop CAR NK pipeline

...led the A round, which also saw participation from SV Health, Takeda Ventures and Astellas Venture Management. COMPANY...
BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...saw participation from new investors Qiming Venture Partners USA, Surveyor Capital, Cormorant Asset Management, MP Healthcare Venture Management...
BioCentury | Jul 21, 2020
Deals

With deal for Tizona, Gilead places latest bet on cancer immunosuppression

...MPM’s Luke Evnin holds a board seat. Other series A investors included Amgen Ventures, Astellas Venture Management...
BioCentury | May 29, 2020
Finance

Taiho’s new modality search engine

...corporate venture fund in 2016, after a four-year stint as president and CEO of Astellas Venture Management...
BioCentury | May 13, 2020
Emerging Company Profile

QurAlis taking three ALS programs toward clinic with $42M series A

...Also participating were Droia Ventures, Mitsui Global Investment, Dolby Family Ventures, Amgen Ventures, MP Healthcare Venture Management...
...Dementia Discovery Fund, Droia Ventures, Mitsui Global Investment, Dolby Family Ventures, Amgen Ventures, MP Healthcare Venture Management...
BioCentury | Mar 27, 2020
Emerging Company Profile

Redpin debuts chemogenetic platform for neurology, raises $15.5M

...has raised $34 million in series A funding from Versant Ventures, MPM Capital and Astellas Venture Management...
BioCentury | Jan 10, 2020
Financial News

Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas

...participation by new investors Novartis Institutes for BioMedical Research (NIBR), Pitango Venture Capital, and Astellas Venture Management...
BioCentury | Nov 5, 2019
Finance

Coda’s chemogenetics convinces investors to re-up in series A extension

...Ventures, brings the round’s total to $34 million. Fellow existing investors MPM Capital and Astellas Venture Management...
BioCentury | Sep 16, 2019
Financial News

Sept. 16 Financial Quick Takes: Karyopharm, Mission Bay, Autolus, BenevolentAI, Edigene

...$60 million and said Robert Blazej has joined the firm’s management team. LPs include Astellas Venture Management...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...participating were existing investors MPM Capital, Deerfield Management, UBS Oncology Impact Fund, Arkin Bioventures, Astellas Venture Management...
Items per page:
1 - 10 of 349